Thursday Jun 30, 2022
Thursday Jun 30, 2022

Moderna's 'Spikevax' COVID vaccine approved


Nepalnews
2022 Feb 01, 16:35, Washington
FILE - A medical worker prepares a shot of the Moderna vaccine during a vaccination campaign at Saint Damien Hospital in Port-au-Prince, Haiti, on Tuesday, July 27, 2021. Photo: AP via RSS

Moderna's COVID-19 vaccine 'Spikevax' received full approval from the U.S. Food and Drug Administration (FDA), after more than a year of its "emergency use authorization", reported USA TODAY.

The announcement was made by Moderna on Monday.

"The totality of real-world data and the full (license) for Spikevax in the United States reaffirms the importance of vaccination against this virus. This is a momentous milestone in Moderna's history as it is our first product to achieve licensure in the U.S.," Stephane Bancel, Moderna's CEO, said in a statement.

The full approval is for individuals 18 and older in the two-dose primary series for vaccination however, the booster dose is available under emergency use authorization only, reported the newspaper.

Acting FDA Commissioner Dr Janet Woodcock said that the full approval of Moderna's COVID vaccine "may instill additional confidence" for those who have not yet been vaccinated.

"The public can be assured that Spikevax meets the FDA's high standards for safety, effectiveness and manufacturing quality required of any vaccine approved for use in the United States," Woodcock said.

Notably, about 204 million doses have since been administered in the U.S., according to data from the Centers for Disease Control and Prevention.

READ ALSO:

Moderna COVID-19 vaccine Spikevax FDA approve coronavirus OMICRON Food and Drug Administration Emergency Use Centers for Disease Control and Prevention CDC
Nepal's First Online News Portal
Published by Nepalnews Pvt Ltd
Editor: Raju Silwal
Information Department Registration No. 1505 / 076-77

Contact

KMC-02, UttarDhoka,
Lazimpat, Nepal

Newsroom
+977–01–4445751 / 4445754

E-mail
[email protected] [email protected]

Terms of Use Disclaimer
© NepalNews. 2021 All rights reserved. | Nepal's First News Portal